BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast

BAG-1 (bcl-2-associated athanogene) enhances oestrogen receptor (ER) function and may influence outcome and response to endocrine therapy in breast cancer. We determined relationships between BAG-1 expression, molecular phenotype, response to tamoxifen therapy and outcome in a cohort of breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Millar, E K A, Anderson, L R, McNeil, C M, O'Toole, S A, Pinese, M, Crea, P, Morey, A L, Biankin, A V, Henshall, S M, Musgrove, E A, Sutherland, R L, Butt, A J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634679/
https://www.ncbi.nlm.nih.gov/pubmed/19066611
http://dx.doi.org/10.1038/sj.bjc.6604809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634679/
https://www.ncbi.nlm.nih.gov/pubmed/19066611
http://dx.doi.org/10.1038/sj.bjc.6604809

Ejemplares similares